An analyst from JP Morgan has decided to maintain their Overweight rating on Kenvue, which currently sits at a price target ...
Kenvue's strong brands continued to gain market shares, showing progress despite challenges in the consumer environment. Read ...
Kenvue beat Wall Street estimates for second-quarter profit and revenue on Tuesday, helped primarily by better-than-expected ...
Kenvue’s stock surged Tuesday toward a record gain, after the parent of consumer health brands including Band-Aid, Tylenol ...
Kenvue Inc., the owner of the Tylenol and Neutrogena brands, jumped after reporting sales that topped estimates, bucking a ...
Kenvue’s stock surged Tuesday toward a record gain, after the parent of consumer health brands including Band-Aid, Tylenol ...
The NAD took issue with ASO’s claims that its hydrocolloid bandages lead to “2x faster healing” compared to traditional dry ...
We recently compiled a list of the 10 Best Dividend Aristocrats with Over 3% Yield. In this article, we are going to take a ...
Kenvue sees stock rise following strong Q2 2024 results. Despite a slight dip in sales, revenue of $4 billion beat ...
NEW BRUNSWICK, N.J. - Kenvue Inc . (NYSE: NYSE:KVUE) reported second quarter earnings that met analyst expectations, while ...
Kenvue Inc. (NYSE: KVUE) ("Kenvue" or the "Company"), the world's largest pure-play consumer health company by revenue, is ...
Adjusted Diluted EPS 1 was $0.32 Productivity gains fuel accelerated investment in brands for future growth Reaffirms Outlook ...